Key Takeaways for the Treatment of NRG1 Fusion–Positive Malignancies

Alexander I. Spira, MD, PhD, and Joshua K. Sabari, MD, conclude their discussion with key takeaways on the evolving treatment of patients with NRG1 fusion–positive malignancies.